Sebastian Johannes Schober

8PUBLICATIONS
36CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 09, 2023
The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma.

Sebastian Johannes Schober, Caroline Schoening, Jennifer Eck

|Aug 10, 2022
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus.

Jana Koch, Sebastian J Schober, Sruthi V Hindupur

|Jan 28, 2022
Tumor Targeting with Bacterial Shiga Toxin B Subunit in Genetic Porcine Models for Colorectal Cancer and Osteosarcoma.

Maximilian Ehrenfeld, Anna Schrade, Tatiana Flisikowska

|Nov 27, 2021
Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing's Sarcoma, Enhancing T Cell Cytotoxicity.

Emilie Biele, Sebastian J Schober, Carolin Prexler

|Aug 27, 2021
Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function.

Hendrik Gassmann, Kira Schneider, Valentina Evdokimova

|Aug 10, 2021
Correction to: No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.

U Thiel, S J Schober, A Ranft

Pageof 2

Frequent Collaborators

3 joint publications

Uwe Thiel

2 joint publications

M Ussowicz

2 joint publications

I Kazantsev

2 joint publications

T Klingebiel